Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T26628 |
Andolast
CR2039,CR-2039,CR 2039 |
||
Andolast, also known as CR-2039, an anti-allergic agent for the treatment of bronchial asthma, chronic obstructive pulmonary disease (COPD). Andolast acts at different cellular levels to inhibit immunoglobulin E synthesis. Andolast proved to be significan |